Mona Ashiya
Director · Yarrow Bioscience, Inc.
- 2025
- Jul 30, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mona Ashiya files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Arundathy N. Pandite - $409K in STTK purchases and sales in the last 12 months
- Clay B. Siegall - $250K in STTK purchases and sales in the last 12 months
- Abhinav A. Shukla - $183K in STTK purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - STTK
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mona Ashiya?
Mona Ashiya is a corporate insider, tracked as Director of Yarrow Bioscience, Inc. (YARW). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Mona Ashiya last file a Form 4?
The most recent primary Form 4 on record is dated 30 July 2026, one of 6 filings going back to 2025.
Has Mona Ashiya been buying or selling stock?
Recorded transactions: 8 open-market purchases ($5.47M) and 0 open-market sales across all tracked filings.
